Equities analysts expect H. B. Fuller Company (NYSE:FUL) to post sales of $554.71 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for H. B. Fuller’s earnings. The lowest sales estimate is $543.93 million and the highest is $563.40 million. H. B. Fuller posted sales of $512.86 million during the same quarter last year, which suggests a positive year over year growth rate of 8.2%. The firm is expected to report its next earnings results on Wednesday, September 20th.
According to Zacks, analysts expect that H. B. Fuller will report full-year sales of $554.71 million for the current year, with estimates ranging from $2.18 billion to $2.22 billion. For the next fiscal year, analysts forecast that the firm will post sales of $2.31 billion per share, with estimates ranging from $2.27 billion to $2.36 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow H. B. Fuller.
H. B. Fuller (NYSE:FUL) last announced its quarterly earnings data on Wednesday, June 28th. The specialty chemicals company reported $0.62 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.67 by $0.05. The firm had revenue of $561.65 million for the quarter. H. B. Fuller had a net margin of 5.23% and a return on equity of 13.32%. During the same quarter last year, the firm earned $0.67 EPS.
FUL has been the topic of a number of recent analyst reports. Citigroup Inc. increased their price target on shares of H. B. Fuller from $55.00 to $59.00 and gave the stock a “buy” rating in a report on Tuesday, April 4th. Zacks Investment Research downgraded shares of H. B. Fuller from a “hold” rating to a “sell” rating in a report on Monday, June 5th. Finally, BidaskClub raised shares of H. B. Fuller from a “hold” rating to a “buy” rating in a report on Saturday, June 10th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $52.40.
WARNING: “H. B. Fuller Company (FUL) Expected to Post Quarterly Sales of $554.71 Million” was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://stocknewstimes.com/2017/08/17/h-b-fuller-company-ful-expected-to-post-quarterly-sales-of-554-71-million-2-updated-updated.html.
Shares of H. B. Fuller (NYSE FUL) traded up 0.17% during mid-day trading on Wednesday, hitting $51.62. 172,430 shares of the stock traded hands. The firm has a 50 day moving average of $51.74 and a 200 day moving average of $50.91. H. B. Fuller has a 12 month low of $41.52 and a 12 month high of $54.32. The stock has a market cap of $2.61 billion, a price-to-earnings ratio of 23.59 and a beta of 1.68.
The company also recently declared a quarterly dividend, which will be paid on Thursday, August 10th. Investors of record on Thursday, July 27th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date is Tuesday, July 25th. H. B. Fuller’s dividend payout ratio (DPR) is presently 27.40%.
H. B. Fuller declared that its board has authorized a share buyback program on Thursday, April 6th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the specialty chemicals company to purchase up to 7.9% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board believes its stock is undervalued.
In related news, VP Dietrich J. Crail acquired 970 shares of H. B. Fuller stock in a transaction on Wednesday, July 12th. The stock was bought at an average cost of $51.41 per share, for a total transaction of $49,867.70. Following the completion of the transaction, the vice president now owns 970 shares of the company’s stock, valued at approximately $49,867.70. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP David W. Moorman sold 1,683 shares of the company’s stock in a transaction on Monday, May 1st. The stock was sold at an average price of $52.76, for a total transaction of $88,795.08. The disclosure for this sale can be found here. Corporate insiders own 3.10% of the company’s stock.
Institutional investors have recently bought and sold shares of the company. BlackRock Inc. increased its stake in shares of H. B. Fuller by 10,635.2% in the first quarter. BlackRock Inc. now owns 6,217,806 shares of the specialty chemicals company’s stock worth $320,590,000 after buying an additional 6,159,886 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of H. B. Fuller by 7.5% in the first quarter. Vanguard Group Inc. now owns 5,055,505 shares of the specialty chemicals company’s stock worth $260,662,000 after buying an additional 351,478 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of H. B. Fuller by 4.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,004,463 shares of the specialty chemicals company’s stock worth $103,353,000 after buying an additional 80,277 shares in the last quarter. Champlain Investment Partners LLC increased its stake in shares of H. B. Fuller by 53.9% in the first quarter. Champlain Investment Partners LLC now owns 1,664,330 shares of the specialty chemicals company’s stock worth $85,813,000 after buying an additional 582,945 shares in the last quarter. Finally, Janus Capital Management LLC increased its stake in shares of H. B. Fuller by 425.6% in the first quarter. Janus Capital Management LLC now owns 1,545,716 shares of the specialty chemicals company’s stock worth $79,697,000 after buying an additional 1,251,620 shares in the last quarter. Institutional investors own 93.39% of the company’s stock.
About H. B. Fuller
H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.
Get a free copy of the Zacks research report on H. B. Fuller (FUL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for H. B. Fuller Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller Company and related companies with MarketBeat.com's FREE daily email newsletter.
